Profile
Dr. S.
K.
Tanaka is Vice President-Research & Development at Paratek Pharmaceuticals, Inc.
Dr. Tanaka was previously employed as Vice President-Research & Development by Paratek Pharmaceuticals, Inc. /Old/, Senior Director by PathoGenesis Corp, Project Leader by Abbott Laboratories, a Principal by SCHWARZ PHARMA, Inc., and Scientist by E.R.
Squibb & Sons LLC.
He received his undergraduate degree from the University of Washington and a doctorate degree from Northwestern University.
Former positions of S. Ken Tanaka
| Companies | Position | End |
|---|---|---|
| PARATEK PHARMACEUTICALS, INC. | Chief Tech/Sci/R&D Officer | - |
| E. R. Squibb & Sons LLC | Chief Tech/Sci/R&D Officer | - |
Schwarz Pharma, Inc.
 Schwarz Pharma, Inc. Pharmaceuticals: MajorHealth Technology SCHWARZ PHARMA, Inc. develops and manufactures pharmaceutical products. The company's products include Codimal, Colyte, Edex, Kutrase, Levatol, Robaxin, and Verelan. It was founded in 2003 and is headquartered in Mequon, WI. | Corporate Officer/Principal | - |
PathoGenesis Corp
 PathoGenesis Corp BiotechnologyHealth Technology Part of Novartis AG, PathoGenesis Corp is a company that develops and markets innovative treatments for chronic infectious diseases. The company is based in Seattle, WA. The company was founded by Isaac Blech. PathoGenesis was acquired by Chiron Corp. on September 19, 2000 for $639.75 million. | Director/Board Member | - |
| ABBOTT LABORATORIES | Corporate Officer/Principal | - |
Training of S. Ken Tanaka
| Northwestern University | Doctorate Degree |
| University of Washington | Undergraduate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Listed companies | 2 |
|---|---|
| ABBOTT LABORATORIES | Health Technology |
| PARATEK PHARMACEUTICALS, INC. | Health Technology |
| Private companies | 4 |
|---|---|
Paratek Pharmaceuticals, Inc. /Old/
 Paratek Pharmaceuticals, Inc. /Old/ Pharmaceuticals: MajorHealth Technology Paratek Pharmaceuticals, Inc. operates as a pharmaceutical company that focuses on the discovery, development, and commercialization of medicines. The firm’s lead product candidate, omadacycline, is a new tetracycline-derived, broad-spectrum antibiotic being developed for use as a first-line monotherapy for serious community-acquired bacterial infections where antibiotic resistance is of concern for treating physicians. The company was founded by Stuart B. Levy and Walter A. Gilbert on July 3, 1996 and is headquartered in Boston, MA. | Health Technology |
PathoGenesis Corp
PathoGenesis Corp BiotechnologyHealth Technology Part of Novartis AG, PathoGenesis Corp is a company that develops and markets innovative treatments for chronic infectious diseases. The company is based in Seattle, WA. The company was founded by Isaac Blech. PathoGenesis was acquired by Chiron Corp. on September 19, 2000 for $639.75 million. | Health Technology |
Schwarz Pharma, Inc.
Schwarz Pharma, Inc. Pharmaceuticals: MajorHealth Technology SCHWARZ PHARMA, Inc. develops and manufactures pharmaceutical products. The company's products include Codimal, Colyte, Edex, Kutrase, Levatol, Robaxin, and Verelan. It was founded in 2003 and is headquartered in Mequon, WI. | Health Technology |
| E. R. Squibb & Sons LLC |
- Stock Market
- Insiders
- S. Ken Tanaka
